炎症性关节炎残留疾病的定义与患病率:系统文献综述与荟萃分析
该系统综述与荟萃分析评估了类风湿关节炎(RA)、银屑病关节炎(PsA)或中轴型脊柱关节炎(axSpA)中残留疾病的定义方式,并估计其患病率与严重程度。残留疾病定义几乎均基于疾病活动状态但工具/阈值差异大,医师报告和患者报告指标较实验室指标更常用于定义残留疾病。残留疾病患病率显著,例如5-25%的RA和PsA缓解期患者仍有肿胀关节,高达三分之一报告相关疼痛或疲劳;axSpA证据有限。
要点
- 残留疾病定义几乎均基于疾病活动状态,但具体工具和阈值差异很大。
- 医师报告和患者报告指标较实验室指标更常用于定义残留疾病。
- 5-25%的RA和PsA缓解期患者仍有肿胀关节,高达三分之一报告相关疼痛或疲劳。
核心结论
- RA/PsA/axSpA中残留疾病的定义基于多种疾病活动工具/阈值和指标(体征/症状)。
- 残留疾病影响高达一半的患者。
- 未来研究应致力于建立基于共识的残留疾病定义。
研究设计与样本
- 系统综述与荟萃分析,纳入RA/PsA/axSpA的原创研究。
- 提取两个关键残留疾病组分:患者疾病状态和所测量的残留体征/症状指标。
- 患病率(%)和严重程度(工具绝对评分)按指标分析,采用随机效应荟萃分析(≥4项研究)或描述性分析(<4项研究)。
主要发现
- 关于残留疾病定义(59项研究),疾病状态几乎完全基于疾病活动(>99%),但具体工具/阈值差异很大。
- 跨疾病,医师报告指标(66%)和患者报告指标(73%)较实验室指标(46%)更常用于定义残留疾病。
- 外周关节计数、疼痛、身体功能和CRP使用频繁(占研究的42-56%)。
- 残留疾病患病率(84项研究)显著,例如5-25%的RA和PsA缓解期患者仍有肿胀关节,高达三分之一报告相关疼痛或疲劳。
- 对于axSpA,证据有限。
关键数值与推荐
- 疾病状态几乎完全基于疾病活动(>99%的研究)。
- 医师报告指标使用率66%,患者报告指标73%,实验室指标46%。
- 外周关节计数、疼痛、身体功能和CRP使用率42-56%。
- 5-25%的RA和PsA缓解期患者仍有肿胀关节,高达三分之一报告相关疼痛或疲劳。
临床怎么用
- 临床评估RA/PsA/axSpA患者达到治疗目标后,仍需关注残留体征/症状如肿胀关节、疼痛和疲劳。
- 定义残留疾病时应考虑结合医师报告和患者报告指标,而非仅依赖实验室指标。
局限性
- 残留疾病定义中具体工具和阈值差异很大,缺乏共识。
- axSpA的残留疾病证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess how residual disease (i.e., clinically relevant signs/symptoms despite achieving treatment targets) is defined in rheumatoid arthritis (RA), psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), and estimate the prevalence/severity of residual disease in these diseases. METHODS: Systematic review of original research in RA/PsA/axSpA. Two key residual disease components were extracted: (1) the patient's disease state (often remission/low disease activity) and (2) which residual signs/symptoms were measured, e.g. swollen joints or fatigue (indicators of residual disease). Frequencies of the disease states and indicators were described (Objective 1). Prevalence (%) and severity (absolute score on instrument, e.g. fatigue NRS) of residual disease was analysed by indicator, using random effects meta-analysis (≥4 studies) or descriptively (<4 studies) (Objective 2). RESULTS: Regarding residual disease definitions (59 studies), disease states were almost exclusively disease activity-based (>99%), but with much variation in specific instruments/thresholds. Across diseases, physician-reported (66%) and patient-reported (73%) indicators were used more often than laboratory indicators to define residual disease (46%). Especially peripheral joint counts, pain, physical function and CRP were frequently used (42-56% of studies). The prevalence of residual disease (84 studies) was notable. For example, 5-25% of RA and PsA patients in remission still had swollen joints, and up to one-third reported relevant pain or fatigue. For axSpA, evidence was limited. CONCLUSION: Residual disease definitions in RA/PsA/axSpA are based on various disease activity instruments/thresholds and indicators (signs/symptoms). Residual disease affects up to half of patients. Future research should aim for a consensus-based definition of residual disease.
引用
- Webers C, Smits ML, Renet E, et al. Definition and prevalence of residual disease in inflammatory arthritis: a systematic literature review and meta-analysis. Semin Arthritis Rheum. 2026. PMID: 42485861. doi:10.1016/j.semarthrit.2026.153044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。